Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulin.

Intravenous immunoglobulin (IVIG) is used as the standard replacement therapy for patients with primary antibody deficiencies. A previous study of adverse reactions in patients self-infusing at home over 1 year showed an overall reaction rate of 0.7%. A larger prospective study is reported here, inv...

全面介绍

书目详细资料
Main Authors: Brennan, V, Salomé-Bentley, N, Chapel, H
格式: Journal article
语言:English
出版: 2003